Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Dompé Farmaceutici S.p.A: Clinical Trials & FDA Approval Profile

Dompé Farmaceutici S.p.A (Global / Institutional) sponsors 19 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 4 active protocols (4 recruiting now), 8 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)36.8%
Median Closed Enrollment vs National (145 pts)85 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Dompé Farmaceutici S.p.A
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)19
Active Pipeline (Recruiting Now)4 (4)
Completed vs Stopped Early8 / 7 (36.8%)
Median Closed Actual Enrollment85 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Dompé Farmaceutici S.p.A
Hospital Research SiteLocationShared Protocols
University of Colorado Anschutz Medical CampusAurora, CO3
Johns Hopkins Hospital and Kimmel Cancer CenterBaltimore, MD3
Emory Winship Cancer InstituteAtlanta, GA3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Dompé Farmaceutici S.p.A
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT07453888Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)Phase IIIRECRUITING
NCT07395232An Efficacy and Safety Study of DFL24498 in the Treatment of AKCPhase IIIRECRUITING
NCT07519902An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCEDPhase IIIRECRUITING
NCT04628481A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell FunctionPhase IITERMINATED

Explore interactive annual charts and M&A subsidiary rollups in the Dompé Farmaceutici S.p.A Interactive Dossier, benchmark peers in Ophthalmology and Sensory, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI